TARDBP and amyotrophic lateral sclerosis: The second study used a non-biased screening approach in CSF from people with ALS or frontotemporal dementia and found 18 de novo cryptic peptides across 13 genes.96 PET ligands for TDP-43 are being developed with the aim to track in vivo pathology,97 and will require validation before clinical use in human beings.